Skip to main content

You are here


Why are we There?

  • Armed conflict
  • Endemic/Epidemic disease
  • Healthcare exclusion

Our Work


  • Médecins Sans Frontières handed over its multidrug-resistant tuberculosis (MDR-TB) activities in Abkhazia in August 2014, and focused on patients with extensively drug-resistant forms (XDR-TB) of the disease in the capital Tbilisi.
  • Two new drugs – bedaquiline and delamanid – have recently become available to some patients who have no other treatment options left.
  • In September 2014, Médecins Sans Frontières started supporting the National Center for Tuberculosis and Lung Diseases in Tbilisi. Training and technical support were provided to hospital staff to improve detection and clinical care of XDR-TB patients, and to facilitate their early access to new drugs.
  • A grant for activities in Tbilisi was under discussion with UNITAID at the end of 2014.


Handing over activities in Abkhazia

  • In August 2014, Médecins Sans Frontières handed over its access to care programme for elderly and vulnerable people, as well as its TB and MDR-TB activities in Abkhazia, to a local NGO set up by former Médecins Sans Frontières staff.
  • Médecins Sans Frontières continues to facilitate the transportation of sputum samples from Abkhazia to the culture laboratory in Tbilisi. 


For the latest news on where we work visit:

Médecins Sans Frontières has worked in the country since 1993 and at the end of 2014, Médecins Sans Frontières had 28 staff in Georgia.